Sanjay Kaul

1991–2025 年に発表

69
論文数
24,836
被引用数
58
h 指数
67
i10 指数

被引用数

Sanjay Kaul の年別被引用数1992 年: 被引用 2 件1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 6 件1997 年: 被引用 4 件1998 年: 被引用 7 件1999 年: 被引用 17 件2000 年: 被引用 28 件2001 年: 被引用 60 件2002 年: 被引用 64 件2003 年: 被引用 101 件2004 年: 被引用 116 件2005 年: 被引用 119 件2006 年: 被引用 104 件2007 年: 被引用 136 件2008 年: 被引用 143 件2009 年: 被引用 113 件2010 年: 被引用 127 件2011 年: 被引用 126 件2012 年: 被引用 135 件2013 年: 被引用 137 件2014 年: 被引用 141 件2015 年: 被引用 123 件2016 年: 被引用 102 件2017 年: 被引用 102 件2018 年: 被引用 123 件2019 年: 被引用 453 件2020 年: 被引用 550 件2021 年: 被引用 783 件2022 年: 被引用 660 件2023 年: 被引用 494 件2024 年: 被引用 806 件2025 年: 被引用 363 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,743 件、この内訳の 20.3%イギリス: 引用元論文 1,069 件、この内訳の 7.9%ドイツ: 引用元論文 852 件、この内訳の 6.3%イタリア: 引用元論文 798 件、この内訳の 5.9%カナダ: 引用元論文 653 件、この内訳の 4.8%中国: 引用元論文 613 件、この内訳の 4.5%オランダ: 引用元論文 595 件、この内訳の 4.4%フランス: 引用元論文 506 件、この内訳の 3.7%日本: 引用元論文 426 件、この内訳の 3.2%スペイン: 引用元論文 398 件、この内訳の 3%オーストラリア: 引用元論文 358 件、この内訳の 2.7%スイス: 引用元論文 323 件、この内訳の 2.4%
0%20.3%その他 30.9%

分野

  • Medicine83.4%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Immunology and Microbiology4.3%
  • Engineering1.9%
  • Nursing0.8%
  • Health Professions0.5%
  • その他3.2%

トピック

  • Diabetes Treatment and Management9.1%
  • Heart Failure Treatment and Management4.8%
  • Cardiovascular Function and Risk Factors4.3%
  • Coronary Interventions and Diagnostics3.8%
  • Acute Myocardial Infarction Research3.4%
  • Antiplatelet Therapy and Cardiovascular Diseases3.2%
  • その他71.4%

共著者

全論文

検索で開く
  1. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie‐France Seronde, Jindřich Špinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faı̈ez Zannad - New England Journal of Medicine 2020 被引用: 5,037

  2. Standardized Bleeding Definitions for Cardiovascular Clinical Trials

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2011 被引用: 4,423

  3. Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

    著者: , , , , , , , , , , , , , , , , , , , - Circulation 2021 被引用: 192

  4. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roland E. Schmieder, Christoph Wanner, Pantelis Sarafidis, Juliana C.N. Chan, László Rosivall, Joseph A. Eustace, Ehud Grossman, Yoram Yagil, Giuseppe Remuzzi, Daisuke Koya, Takashi Wada, Magdalena Madero Rovalo, Ron T. Gansevoort, Adriaan Kooy, Trine Finnes, Froilan DeLeon, Janusz Gumprecht, Fernando Teixeira e Costa, Alexander Dreval, Anantharaman Vathsala, Aslam Amod, Sin Gon Kim, Byung‐Wan Lee, Julio Pascual Santos, Bengt-Olov Tengmark, Michel Burnier, Chien‐Te Lee, Sukit Yamwong, Ramazan Sarı, Kieran McCafferty, Borys Mankovsky, Sharon G. Adler, Linda F. Fried, Mark V. Williams, Tran Quang Khanh, Diego Aizenberg, Inés Bartolacci, Diego Besada, Julio Bittar, Mariano Chahin, Alicia Elbert, Elizabeth Gelersztein, Alberto Liberman, Laura Maffei, Federico Pérez Manghi, Hugo Sanabria, Gloria Viñes, Alfredo Wassermann, Walter P. Abhayaratna, Shamasunder Acharya, Elif I. Ekinci, Darren Lee, Peak Mann Mah, Craig Nelson, David Packham, Alexia Pape, Simon Roger, Hugo Stephenson, Michael Suranyi, Gary Wittert, Elizabeth Vale, Martin Clodi, Christoph Ebenbichler, Evelyn Fließer-Görzer, Ursula Hanusch, Michael Krebs, Karl Lhotta, Bernhard Ludvik, Gert Mayer, Peter Neudorfer ほか 1,447 名 - Annals of Internal Medicine 2023 被引用: 88

  5. From Vulnerable Plaque to Vulnerable Patient

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wolfgang Köenig, Robert A. Lodder, Keith L. March, Jasenka Demirovic, Mohamad Navab, Silvia G. Priori, Mark D. Rekhter, Raymond D. Bahr, Scott M. Grundy, Roxana Mehran, Antonio Colombo, Eric Boerwinkle, Christie M. Ballantyne, William Insull, Robert S. Schwartz, Robert A. Vogel, Patrick W. Serruys, Göran K. Hansson, David P. Faxon, Sanjay Kaul, Helmut Drexler, Philip Greenland, James E. Muller, Renu Virmani, Paul M. Ridker, Douglas P. Zipes, Prediman K. Shah, James T. Willerson - Circulation 2003 被引用: 2,671

  6. Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , - JAMA Cardiology 2023 被引用: 60

  7. Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2022 被引用: 55

  8. Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum

    著者: , , , , , , , , , , , , - Diabetes Care 2017 被引用: 369

  9. 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis

    著者: , , , , , , , , - Journal of the American College of Cardiology 2017 被引用: 506

  10. Risk of Bias in Randomized Clinical Trials Comparing Transcatheter and Surgical Aortic Valve Replacement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2023 被引用: 58

  11. Impact of High Volume Energy Drink Consumption on Electrocardiographic and Blood Pressure Parameters: A Randomized Trial

    著者: , , , , , , , , , , , , , - Journal of the American Heart Association 2019 被引用: 110

  12. Toll-Like Receptor-4 Is Expressed by Macrophages in Murine and Human Lipid-Rich Atherosclerotic Plaques and Upregulated by Oxidized LDL

    著者: , , , , , , , , , , , - Circulation 2001 被引用: 667

  13. Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis

    著者: , , - New England Journal of Medicine 2014 被引用: 386

  14. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton consensus panel

    著者: , , , , , , , , , , , , , , , - The American Journal of Cardiology 2000 被引用: 395

  15. Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-Analysis

    著者: , , - PLoS ONE 2015 被引用: 219

  16. The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience

    著者: , , - New England Journal of Medicine 2013 被引用: 204

  17. ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

    著者: , , , , , - Circulation 2010 被引用: 357

  18. Oxidized Low-Density Lipoprotein Regulates Matrix Metalloproteinase-9 and Its Tissue Inhibitor in Human Monocyte-Derived Macrophages

    著者: , , , , , , , - Circulation 1999 被引用: 299

  19. ACCF/AHA New Insights Into the Methodology of Performance Measurement

    著者: , , , , , , , , , , , - Circulation 2010 被引用: 100

  20. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2019 被引用: 29

  21. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jane A. Linderbaum, David J. Moliterno, Debabrata Mukherjee, Robert S. Rosenson, James H. Stein, Howard H. Weitz, Deborah J. Wesley - Journal of the American College of Cardiology 2012 被引用: 406

  22. Trial and Error

    著者: , - Journal of the American College of Cardiology 2010 被引用: 270

  23. The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease

    著者: , , , , , , , , , - European Heart Journal 2013 被引用: 218

  24. Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease

    著者: , , - Journal of the American College of Cardiology 2006 被引用: 175